PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24249003-0	2014	Cyclophosphamide treatment induces rejection of established P815 mastocytoma by enhancing CD4 priming and intratumoral infiltration of P1E/H-2K(d) -specific CD8+ T cells.	Cyclophosphamide	0-16	histocompatibility 2, K1, K region	Mus musculus	139-146	
24249003-6	2014	Importantly, the analysis of CD8+ T cells specific to P1A/H-2L(d) and P1E/H-2K(d) revealed that cyclophosphamide altered the P815-specific CD8 T repertoire by amplifying the response specific to the mutated P1E antigen.	Cyclophosphamide	96-112	histocompatibility 2, K1, K region	Mus musculus	74-81